Daily MDOI Identifier Registry

Browse, search, and export all registered MDOI identifiers. Use the filters below to narrow results.

1157 total identifiers
Reset
Export CSV
Showing 551–600 of 1157
# Identifier Title Resource type Visibility Registered Modified
551 110.0645/CON.2026.00617
A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report
Article Public 2026-07-16 2026-07-16
552 110.0644/CON.2026.00616
Provider Differences in Costs, Utilization, and Quality of Primary Care for Traumatic Brain Injury in the Military
Article Public 2026-07-16 2026-07-16
553 110.0643/CON.2026.00615
Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics
Article Public 2026-07-16 2026-07-16
554 110.0642/CON.2026.00614
Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare
Article Public 2026-07-16 2026-07-16
555 110.0641/CON.2026.00613
Cost-Effectiveness of Long-Chain Omega-3 Supplementation for the Secondary Prevention of Cardiovascular Disease in the United States
Article Public 2026-07-16 2026-07-16
556 110.0640/CON.2026.00612
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel
Article Public 2026-07-16 2026-07-16
557 110.0639/CON.2026.00611
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel
Article Public 2026-07-16 2026-07-16
558 110.0638/CON.2026.00610
Cost per Opioid-Free Year: A Systematic Review and Summary Analysis
Article Public 2026-07-16 2026-07-16
559 110.0637/CON.2026.00609
Utility Studies in Rare Diseases: A Systematic Literature Review
Article Public 2026-07-16 2026-07-16
560 110.0636/CON.2026.00608
Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies
Article Public 2026-07-16 2026-07-16
561 110.0635/CON.2026.00607
Quality of Care for Patients With Advanced Illness Scale: Development, Preference Elicitation, and Evaluation of Measurement Properties
Article Public 2026-07-16 2026-07-16
562 110.0634/CON.2026.00606
Health State Utilities for Achondroplasia: A Time Trade-Off Study
Article Public 2026-07-16 2026-07-16
563 110.0633/CON.2026.00605
Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations
Article Public 2026-07-16 2026-07-16
564 110.0632/CON.2026.00604
Comparisons of Preferences Toward EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives
Article Public 2026-07-16 2026-07-16
565 110.0631/CON.2026.00603
Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study
Article Public 2026-07-16 2026-07-16
566 110.0630/CON.2026.00602
Building Blocks of Value Creation Within Value-Based Health Systems: A Delphi Study
Article Public 2026-07-16 2026-07-16
567 110.0629/CON.2026.00601
Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study
Article Public 2026-07-16 2026-07-16
568 110.0626/CON.2026.00600
Using Machine Learning to Match Clients and Therapy Providers: Evaluating Clinical Quality and Cost of Care
Article Public 2026-07-14 2026-07-16
569 110.0625/CON.2026.00599
The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands
Article Public 2026-07-14 2026-07-16
570 110.0624/CON.2026.00598
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare
Article Public 2026-07-14 2026-07-14
571 110.0623/CON.2026.00597
Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh Mental Wellbeing Scale, and World Health Organization Well-Being Index 5-Item
Article Public 2026-07-14 2026-07-14
572 110.0622/CON.2026.00596
Understanding the Transition Between Age-Specific Measures of Health-Related Quality of Life: Evidence on the Relationship Between and Comparative Performance of the EQ-5D-Y-5L and EQ-5D-5L
Article Public 2026-07-14 2026-07-14
573 110.0621/CON.2026.00595
The Psychometric Performance of the EQ Health and Wellbeing in Caregivers of Persons Living With Dementia
Article Public 2026-07-14 2026-07-14
574 110.0620/CON.2026.00594
Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports
Article Public 2026-07-14 2026-07-14
575 110.0619/CON.2026.00593
Exemption System for Economic Evaluation Data Submission for Pharmaceuticals in South Korea: Achievements and Challenges
Article Public 2026-07-14 2026-07-14
576 110.0618/CON.2026.00592
Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases
Article Public 2026-07-14 2026-07-14
577 110.0617/CON.2026.00591
The Burden of Mitochondrial Disease: Healthcare and Societal Costs
Article Public 2026-07-14 2026-07-14
578 110.0616/CON.2026.00590
Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review
Article Public 2026-07-14 2026-07-14
579 110.0615/CON.2026.00589
A Scoping Review of Interventions to Reduce the Environmental Footprint of Healthcare
Article Public 2026-07-14 2026-07-14
580 110.0614/CON.2026.00588
The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care
Article Public 2026-07-14 2026-07-14
581 110.0613/CON.2026.00587
Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis
Article Public 2026-07-13 2026-07-14
582 110.0612/CON.2026.00586
Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report
Article Public 2026-07-13 2026-07-14
583 110.0611/CON.2026.00585
Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions
Article Public 2026-07-13 2026-07-13
584 110.0610/CON.2026.00584
Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses
Article Public 2026-07-13 2026-07-13
585 110.0609/CON.2026.00583
Stakeholder Views on the Use and Challenges of Using Early Economic Evaluations in Health Innovation Development in The Netherlands
Article Public 2026-07-13 2026-07-13
586 110.0608/CON.2026.00582
Economic Evaluation Results Are Substantially Affected by Parameter Input Correlation
Article Public 2026-07-13 2026-07-13
587 110.0607/CON.2026.00581
Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making
Article Public 2026-07-13 2026-07-13
588 110.0606/CON.2026.00580
Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States
Article Public 2026-07-13 2026-07-13
589 110.0605/CON.2026.00579
First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis
Article Public 2026-07-13 2026-07-13
590 110.0604/CON.2026.00578
Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States
Article Public 2026-07-13 2026-07-13
591 110.0603/CON.2026.00577
Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer
Article Public 2026-07-13 2026-07-13
592 110.0602/CON.2026.00576
The Argument-Based Approach to Validity Applied to Clinical Outcome Assessments: Some History and Notable Features
Article Public 2026-07-13 2026-07-13
593 110.0601/CON.2026.00575
R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior Code
Article Public 2026-07-13 2026-07-13
594 110.0600/CON.2026.00574
Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy
Article Public 2026-07-13 2026-07-13
595 110.0599/CON.2026.00573
Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Working Group Report
Article Public 2026-07-10 2026-07-13
596 110.0598/CON.2026.00572
Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations
Article Public 2026-07-09 2026-07-10
597 110.0597/CON.2026.00571
Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices
Article Public 2026-07-09 2026-07-09
598 110.0596/CON.2026.00570
Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices
Article Public 2026-07-09 2026-07-09
599 110.0595/CON.2026.00569
Can Adolescents Value the EQ-5D-Y-5L and EQ-5D-5L, and How Do the Values Compare? A Feasibility Study
Article Public 2026-07-09 2026-07-09
600 110.0594/CON.2026.00568
The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level
Article Public 2026-07-09 2026-07-09